1 | personal genome sequencing and | | | | | | | 2 | 0.46% |
2 | company info home about | | | | | | | 1 | 0.23% |
3 | the not to distant | | | | | | | 1 | 0.23% |
4 | cooperation between patients physicians | | | | | | | 1 | 0.23% |
5 | where cooperation between patients | | | | | | | 1 | 0.23% |
6 | future where cooperation between | | | | | | | 1 | 0.23% |
7 | a future where cooperation | | | | | | | 1 | 0.23% |
8 | distant future diagnomics envisions | | | | | | | 1 | 0.23% |
9 | to distant future diagnomics | | | | | | | 1 | 0.23% |
10 | not to distant future | | | | | | | 1 | 0.23% |
11 | in the not to | | | | | | | 1 | 0.23% |
12 | patients physicians and scientists | | | | | | | 1 | 0.23% |
13 | care in the not | | | | | | | 1 | 0.23% |
14 | medical care in the | | | | | | | 1 | 0.23% |
15 | routine medical care in | | | | | | | 1 | 0.23% |
16 | to be part of | | | | | | | 1 | 0.23% |
17 | genomes to be part | | | | | | | 1 | 0.23% |
18 | individual genomes to be | | | | | | | 1 | 0.23% |
19 | of individual genomes to | | | | | | | 1 | 0.23% |
20 | sequencing of individual genomes | | | | | | | 1 | 0.23% |
21 | the sequencing of individual | | | | | | | 1 | 0.23% |
22 | between patients physicians and | | | | | | | 1 | 0.23% |
23 | enables truly personalized medicine | | | | | | | 1 | 0.23% |
24 | will enable the sequencing | | | | | | | 1 | 0.23% |
25 | more accurate information resulting | | | | | | | 1 | 0.23% |
26 | improving individual well being | | | | | | | 1 | 0.23% |
27 | ultimately improving individual well | | | | | | | 1 | 0.23% |
28 | treatments ultimately improving individual | | | | | | | 1 | 0.23% |
29 | and treatments ultimately improving | | | | | | | 1 | 0.23% |
30 | in more effective therapies | | | | | | | 1 | 0.23% |
31 | resulting in more effective | | | | | | | 1 | 0.23% |
32 | information resulting in more | | | | | | | 1 | 0.23% |
33 | accurate information resulting in | | | | | | | 1 | 0.23% |
34 | with more accurate information | | | | | | | 1 | 0.23% |
35 | truly personalized medicine this | | | | | | | 1 | 0.23% |
36 | and targets their diseases | | | | | | | 1 | 0.23% |
37 | individuals and targets their | | | | | | | 1 | 0.23% |
38 | as individuals and targets | | | | | | | 1 | 0.23% |
39 | patients as individuals and | | | | | | | 1 | 0.23% |
40 | recognizes patients as individuals | | | | | | | 1 | 0.23% |